BMRN vs MGM · P/E 40, rev $1.76B vs P/E 64, rev $4.45B
Biomarin Pharmaceutical Inc (BMRN) versus MGM Resorts International (MGM) — a side-by-side from cached financials, not a winner call.
Biomarin Pharmaceutical Inc (BMRN) is a biotechnology company listed on NASDAQ.
MGM Resorts International (MGM) is a resorts & casinos company listed on NYSE.
Latest reported BMRN revenue for 2026-06-30 was $1.76B. Net income was $150.3M. BMRN currently screens at market cap $10.63B and trailing P/E 39.6.
Latest reported MGM revenue for 2026-06-30 was $4.45B. Net income was $292.4M. Revenue was down 0.1% from 2026-03-31 to 2026-06-30. MGM currently screens at market cap $12.01B and trailing P/E 64.3.
BMRN currently screens at market cap $10.63B and trailing P/E 39.6. MGM currently screens at market cap $12.01B and trailing P/E 64.3.
Not investment advice. Open the BMRN and MGM stock pages for the full models.
Not investment advice.